Phase 3 blood loss Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
Tranexamic Acid for Reduction of Transfusion in Abdominal Surgery
Surgical Blood LossTransfusion-dependent AnemiaAbdomen Disease
Ulrich Ronellenfitsch, MD850 enrolled2 locationsNCT06414031
Recruiting
Phase 3
Tranexamic Acid in Adult Spinal Deformity Surgery
Blood Loss, SurgicalSpinal DeformityDegenerative Lumbar Spinal Stenosis
Hospital for Special Surgery, New York100 enrolled1 locationNCT03553186
Recruiting
Phase 2Phase 3
Effect of Early Administration of TXA in Adult Hip Fractures
Postoperative Blood Loss
Ascension Health170 enrolled1 locationNCT05047133
Completed
Phase 3
Efficacy of perioperative Tranexamic Acid in patients undergoing trochanteric hip fracture surgery: A Randomized Placebo Controlled Trial.
blood losship fracture surgery
Dr.Faaiz Ali Shah184 enrolled1 locationACTRN12620001059954
Completed
Phase 3
Comparison of different modes of tranexamic acid administration in patients undergoing total knee arthroplasty.
BLOOD LOSS IN TOTAL KNEE ARTHROPLASTY.
SAMUEL J MACDESSI166 enrolled1 locationACTRN12614000582651
Active
Phase 3Phase 4
Comparison of the efficacy of oxtyocin agonist to oxytocin in the prevention of postpartum hemorrhage (PPH) in women undergoing vaginal delivery
vaginal delivery and blood lossPostpartum Hemorrhage
Dr Farouk720 enrolled1 locationACTRN12608000396325